Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Tumors That Reclassify as Basal-Type ...

Patients in El Paso with certain abdominal cancers now have access to a highly specialized treatment option closer to home ...

Gastric cancer remains a leading cause of cancer mortality worldwide, with peritoneal dissemination accounting for a substantial proportion of recurrences and treatment failures. Cytoreductive surgery ...

Cytoreductive surgery (CRS) combined with intraperitoneal chemotherapy (IPC) has emerged as a cornerstone in the management of peritoneal malignancies, offering a locoregional approach that directly ...

Hyperthermic intraperitoneal chemotherapy (HIPEC) provides an important treatment option that can improve survival for some patients with advanced peritoneal cancer. Managing this disease — and ...

Heating chemotherapy and administering it into the abdominal cavity allows children with desmoplastic small round cell tumors to be treated with minimal side effects. Hyperthermic intraperitoneal ...

Please provide your email address to receive an email when new articles are posted on . Adding hyperthermic intraperitoneal chemotherapy to cytoreductive surgery did not significantly prolong PFS or ...

CHICAGO — Intraperitoneal (IP) chemotherapy is now an alternative to intravenous (IV) administration that "must be discussed" for women with cytoreduced ovarian cancer, several experts said here at ...

Evaluation of the treatment of peritoneal carcinomatosis of colorectal cancer (CRC) with complete cytoreduction and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: A ...

Silverline Hospitals celebrated National Cancer Survivors’ Day, highlighting advancements in oncology and honoring survivors with expert discussions and performances.